4 results match your criteria: "Technology and Clinical Trials[Affiliation]"

This paper investigates the potential of artificial intelligence (AI) and machine learning (ML) to enhance the differentiation of cystic lesions in the sellar region, such as pituitary adenomas, Rathke cleft cysts (RCCs) and craniopharyngiomas (CP), through the use of advanced neuroimaging techniques, particularly magnetic resonance imaging (MRI). The goal is to explore how AI-driven models, including convolutional neural networks (CNNs), deep learning, and ensemble methods, can overcome the limitations of traditional diagnostic approaches, providing more accurate and early differentiation of these lesions. The review incorporates findings from critical studies, such as using the Open Access Series of Imaging Studies (OASIS) dataset (Kaggle, San Francisco, USA) for MRI-based brain research, highlighting the significance of statistical rigor and automated segmentation in developing reliable AI models.

View Article and Find Full Text PDF
Article Synopsis
  • * Patients also suffer from a range of symptoms like cognitive issues, muscle pain, sleep problems, and immune dysfunction.
  • * Diagnosing ME/CFS is tough due to the lack of clear biomarkers, symptom overlap with other conditions, and inconsistent diagnostic criteria, making this literature review essential for understanding the illness and its potential treatments.
View Article and Find Full Text PDF

Background With advancements in natural language processing, tools such as Chat Generative Pre-Trained Transformers (ChatGPT) version 4.0 and Google Bard's Gemini Advanced are being increasingly evaluated for their potential in various medical applications. The objective of this study was to systematically assess the performance of these language learning models (LLMs) on both image and non-image-based questions within the specialized field of Ophthalmology.

View Article and Find Full Text PDF

Background: Early disease detection is emphasized within ophthalmology now more than ever, and as a result, clinicians and innovators turn to deep learning to expedite accurate diagnosis and mitigate treatment delay. Efforts concentrate on the creation of deep learning systems that analyze clinical image data to detect disease-specific features with maximum sensitivity. Moreover, these systems hold promise of early accurate diagnosis and treatment of patients with common progressive diseases.

View Article and Find Full Text PDF